美国：首剂用于新冠病毒疫苗周一临床试验(图)
- 主题发起人 lindamy
- 开始时间
- 注册
- 2005-11-23
- 消息
- 29,988
- 荣誉分数
- 7,575
- 声望点数
- 373
美国已经开始第二个新冠病毒疫苗试验
5 min ago
A second US coronavirus vaccine trial has administered its first dose
From CNN Health’s Gina Yu
The biotechnology company Inovio began a Phase 1 clinical trial of its Covid-19 vaccine this week, with its first dose given to a subject at the University of Pennsylvania on Monday.
The Phase 1 trial is estimated to be completed by late summer of 2020, a spokesperson for Inovio told CNN in an email. It will enroll up to 40 healthy adult volunteers in Philadelphia and Kansas City, Missouri, according to a news release.
The Phase 1 trial is meant to establish that the vaccine is safe and induces a desired response from participants' immune systems. Proving that the vaccine is effective in preventing Covid-19 infection requires follow-up studies involving many more participants, which will take many more months.
Inovio received funding from the Bill and Melinda Gates Foundation and the Coalition for Epidemic Preparedness Innovations.
“In ten weeks from funding, INOVIO manufactured thousands of doses of INO-4800 to support on-going Phase 1 and planned Phase 2 clinical trials,” the news release said.
5 min ago
A second US coronavirus vaccine trial has administered its first dose
From CNN Health’s Gina Yu
The biotechnology company Inovio began a Phase 1 clinical trial of its Covid-19 vaccine this week, with its first dose given to a subject at the University of Pennsylvania on Monday.
The Phase 1 trial is estimated to be completed by late summer of 2020, a spokesperson for Inovio told CNN in an email. It will enroll up to 40 healthy adult volunteers in Philadelphia and Kansas City, Missouri, according to a news release.
The Phase 1 trial is meant to establish that the vaccine is safe and induces a desired response from participants' immune systems. Proving that the vaccine is effective in preventing Covid-19 infection requires follow-up studies involving many more participants, which will take many more months.
Similar to Moderna’s Covid-19 vaccine, which began Phase 1 testing in March, Inovio’s vaccine is also derived from genetic material. However, Inovio’s vaccine -- named INO-4800 -- is derived from DNA, not messenger RNA, which makes up Moderna’s vaccine.
Inovio received funding from the Bill and Melinda Gates Foundation and the Coalition for Epidemic Preparedness Innovations.
“In ten weeks from funding, INOVIO manufactured thousands of doses of INO-4800 to support on-going Phase 1 and planned Phase 2 clinical trials,” the news release said.
- 注册
- 2005-11-23
- 消息
- 29,988
- 荣誉分数
- 7,575
- 声望点数
- 373
5 hr 37 min ago
Germany says it has approved the first clinical vaccine trial
From CNN's Stephanie Halasz
The first clinical trial for a Covid-19 vaccine has been approved in Germany, the country's Federal Institute for Vaccines and Biomedical Drugs has said.
The potential vaccine is being developed by biotech company BioNTech in Mainz, Germany.
An exterior view of biopharmaceutical company BioNTech in Mainz, Germany, pictured on March 18. Ronald Wittek/EPA-EFE/Shutterstock
The Paul Ehrlich Institute, the Federal Agency, says it was able to complete the approval process in four days.
Another human vaccine trial is set to get underway at Oxford University in the UK on Thursday, the British health secretary confirmed this week.
And a separate trial at London's Imperial College is also in the pipeline for June, with researchers asking for volunteers.
Germany says it has approved the first clinical vaccine trial
From CNN's Stephanie Halasz
The first clinical trial for a Covid-19 vaccine has been approved in Germany, the country's Federal Institute for Vaccines and Biomedical Drugs has said.
The potential vaccine is being developed by biotech company BioNTech in Mainz, Germany.
An exterior view of biopharmaceutical company BioNTech in Mainz, Germany, pictured on March 18. Ronald Wittek/EPA-EFE/Shutterstock
The Paul Ehrlich Institute, the Federal Agency, says it was able to complete the approval process in four days.
Another human vaccine trial is set to get underway at Oxford University in the UK on Thursday, the British health secretary confirmed this week.
And a separate trial at London's Imperial College is also in the pipeline for June, with researchers asking for volunteers.
- 注册
- 2005-11-23
- 消息
- 29,988
- 荣誉分数
- 7,575
- 声望点数
- 373
8 hr 29 min ago
British scientists call for volunteers for human trials of coronavirus vaccine
From CNN's Simon Cullen
Imperial College London is seen on March 27 as lockdown remains in place across the UK to help curb the spread of the coronavirus. Aaron Chown/PA Images via Getty Images
Coronavirus vaccine researchers in London are asking for volunteers to take part in human trials in June.
A team at Imperial College London has been carrying out tests on animals since February and has secured government funding to fast-track its work.
Shattock said the coronavirus is not as difficult a target compared with other diseases.
“It’s very different from influenza, which changes every year,” he said. “Scientifically there’s a very high chance of success of getting a vaccine.”
British scientists call for volunteers for human trials of coronavirus vaccine
From CNN's Simon Cullen
Imperial College London is seen on March 27 as lockdown remains in place across the UK to help curb the spread of the coronavirus. Aaron Chown/PA Images via Getty Images
Coronavirus vaccine researchers in London are asking for volunteers to take part in human trials in June.
A team at Imperial College London has been carrying out tests on animals since February and has secured government funding to fast-track its work.
The college said early findings show that in animals, the vaccine does have a positive effect.
Shattock said the coronavirus is not as difficult a target compared with other diseases.
“It’s very different from influenza, which changes every year,” he said. “Scientifically there’s a very high chance of success of getting a vaccine.”
- 注册
- 2012-09-04
- 消息
- 64,346
- 荣誉分数
- 11,952
- 声望点数
- 1,373
5 hr 37 min ago
Germany says it has approved the first clinical vaccine trial
From CNN's Stephanie Halasz
The first clinical trial for a Covid-19 vaccine has been approved in Germany, the country's Federal Institute for Vaccines and Biomedical Drugs has said.
The potential vaccine is being developed by biotech company BioNTech in Mainz, Germany.
An exterior view of biopharmaceutical company BioNTech in Mainz, Germany, pictured on March 18. Ronald Wittek/EPA-EFE/Shutterstock
The Paul Ehrlich Institute, the Federal Agency, says it was able to complete the approval process in four days.
Another human vaccine trial is set to get underway at Oxford University in the UK on Thursday, the British health secretary confirmed this week.
And a separate trial at London's Imperial College is also in the pipeline for June, with researchers asking for volunteers.
比中国晚了3个星期。
陈薇将军打了中国乃至全世界第一针疫苗，
没过多久又一个人说他是中国第一针疫苗，国内网友眼尖，问是怎么回事儿？
这一问才知道，陈将军到岗之前可能打了防SARS疫苗，所以，这第一针就好像孙杨的奖牌一样不算数了，呵呵
